申请人:Aboagye Eric Ofori
公开号:US20100063144A1
公开(公告)日:2010-03-11
There is provided a compound of formula (I) wherein R
1a
, R
2a
, R
3
, X
1
to X
6
, a, b and c have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, inhibitors of HDAC enzyme activity, and thus, in particular, in the treatment of conditions where inhibition of HDAC enzyme activity is required.
提供了一种化合物,其分子式为(I),其中R1a,R2a,R3,X1至X6,a,b和c的含义在描述中给出,这些化合物可用作HDAC酶活性的抑制剂,或者可用作其前药,因此特别适用于需要抑制HDAC酶活性的疾病的治疗。